Novo Nordisk A/S (NVO)
48.73
-0.39
(-0.79%)
USD |
NYSE |
Feb 11, 16:00
48.81
+0.08
(+0.16%)
After-Hours: 19:58
Novo Nordisk Market Cap : 216.69B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.51B |
| Evaxion AS | 20.84M |
| Regeneron Pharmaceuticals, Inc. | 82.40B |
| Viking Therapeutics, Inc. | 3.231B |
| DBV Technologies SA | 617.69M |
Market Cap Related Metrics
| PE Ratio | 14.05 |
| PS Ratio | 4.640 |
| PEG Ratio | 2.488 |
| Price to Book Value | 9.367 |
| Price to Free Cash Flow | 49.28 |
| Price | 48.73 |
| Earnings Yield | 7.12% |
| PEGY Ratio | 1.533 |
| Operating PE Ratio | 11.27 |
| Normalized PE Ratio | 14.05 |